PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933331
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933331
The global brain implants market is witnessing rapid growth due to the rising prevalence of neurological disorders, increasing adoption of advanced neuromodulation therapies, and strong investments in research and development by medical device manufacturers. Brain implants, also known as neural implants, are surgically implanted devices that electrically stimulate specific regions of the brain to manage neurological conditions such as epilepsy, Parkinson's disease, Alzheimer's disease, and schizophrenia.
In 2025, the global brain implants market size was valued at USD 2.36 billion. The market is projected to grow from USD 2.62 billion in 2026 to USD 6.09 billion by 2034, exhibiting a strong CAGR of 12.80% during the forecast period (2026-2034). North America dominated the global market with a 45.53% share in 2025, supported by advanced healthcare infrastructure, high diagnosis rates, and favorable reimbursement policies.
COVID-19 Impact
The COVID-19 pandemic had a negative short-term impact on the brain implants market. Temporary hospital shutdowns, postponement of elective neurosurgeries, and reduced patient visits significantly slowed market growth. According to the National Library of Medicine (November 2021), neurosurgical referrals declined by 33.6%, while operations dropped by 55.6% during the pandemic.
Key players experienced revenue declines due to supply chain disruptions and delayed procedures. For instance, Boston Scientific's neuromodulation segment recorded revenues of USD 761.0 million in 2020, reflecting a 12.8% decline from 2019. However, the market began recovering in 2021 with the resumption of surgeries and improved patient footfall.
Market Trends
Rising Focus on Flexible and Advanced Neural Probes
One of the key trends in the brain implants market is the development of flexible probes to reduce scarring caused by traditional silicon-based implants. Research institutions are exploring bendable materials such as silk fibroin and alginate to better match brain tissue softness.
In June 2023, the University of Glasgow collaborated on research exploring advanced biological materials for flexible brain probes. Additionally, the integration of cell therapy with bioelectronics is emerging as a breakthrough trend. In March 2023, the University of Cambridge developed a neural implant capable of restoring limb function in paralyzed patients.
Market Growth Drivers
Rising Prevalence of Neurological Disorders
The growing incidence of neurological disorders is a primary driver of market growth. According to WHO (January 2022), 24 million people globally suffer from schizophrenia, while Alzheimer's Association (March 2023) reported 6.7 million Americans aged 65+ living with Alzheimer's disease, projected to reach 13.8 million by 2060.
Awareness campaigns, improving diagnosis rates, and rising healthcare expenditure are further driving the adoption of brain implants globally.
Increasing R&D Investments
Medical device manufacturers are heavily investing in R&D to develop innovative and personalized brain implant technologies. In January 2023, Precision Neuroscience focused on developing the Layer 7 Cortical Interface to assist patients with paralysis, highlighting the innovation-driven growth of the market.
Restraining Factors
Despite strong growth prospects, high treatment costs and limited reimbursement in emerging economies restrict market adoption. For example, the average cost of a deep brain stimulation device ranges between USD 28,000 and USD 29,000 in Turkey, limiting accessibility in low-income regions. Additionally, poor healthcare infrastructure and limited disease awareness further restrain market penetration.
By Product
Deep brain stimulation dominated the market with a 65.60% share in 2026, owing to multiple FDA approvals. Vagus nerve stimulation is expected to grow significantly, while responsive neurostimulation is projected to expand at the fastest CAGR due to personalized, real-time treatment capabilities.
By Application
Epilepsy dominated the market in 2024, while Parkinson's disease accounted for 33.94% share in 2026. Alzheimer's disease is expected to grow at a higher CAGR due to rising prevalence and new product approvals.
By End-user
Hospitals led the market with a 73.35% share in 2026, driven by higher surgical volumes and improved neurological care infrastructure.
Key Industry Players
Major players include Medtronic, Boston Scientific Corporation, Abbott, NeuroPace, LivaNova PLC, and ALEVA Neurotherapeutics. Medtronic leads the market with strong product offerings and R&D investments.
Conclusion
The global brain implants market is poised for robust growth, expanding from USD 2.36 billion in 2025 to USD 6.09 billion by 2034, driven by the rising prevalence of neurological disorders, increasing adoption of neuromodulation therapies, and strong R&D investments by key players. Although high treatment costs and limited reimbursement in emerging economies pose challenges, ongoing technological advancements, growing awareness, and expanding healthcare infrastructure are expected to support sustained market expansion over the forecast period.
Segmentation By Product
By Application
By End-user
By Region